International Myeloma Foundation Responds to ICER Report

The International Myeloma Foundation (IMF) recently spoke out against the Institute for Clinical and Economic Review’s (ICER) report on the value of myeloma drugs. Find out what IMF had to say here. (Source: Journal of Clinical Pathways, 5/26/16)

You might also be interested in:

Review of Influence: The Institute for Clinical and Economic Review February 26, 2019
ICER Sets Out Against Unjustified Price Increases in New Report February 7, 2019
ICER Using New Economic Modeling Platform for Value Assessment August 24, 2018
ICER Releases Report on Therapies for Long-term Prophylaxis HAE November 16, 2018
ICER Releases Draft Scoping Document for Peanut Allergy Treatments November 22, 2018
Article: Plans to Reduce Drug Prices Could Limit Treatments to… October 30, 2018
ICER Releases Report on Inotersen, Patisiran July 21, 2018